Interestingly, treatment with KIR-ESS peptide significantly reduced pY-STAT3 expression levels in both untreated and IL-22-treated SCC xenografts, in particular in those areas surrounding tumor mass (Figure 7C and data not shown) likely enriched of keratinocytes responsible for maintaining tumor growth [34]. This evidence concerns the gene IL22 and neoplasm.